Hayadan > Anticancer drugs
Anticancer drugs
- Weizmann Institute
- February 15, 2013
- No comments
- The science service
- November 25, 2012
- 5 תגובות
- Scientific American Israel
- February 8, 2012
- One response
- Dr. Moshe Nahamani
- February 21, 2011
- One response
- Lotem Eliyahu
- October 9, 2010
- No comments
- Weizmann Institute
- October 6, 2010
- 3 תגובות
- Weizmann Institute
- September 26, 2010
- No comments
- Dr. Moshe Nahamani
- August 19, 2010
- No comments
- Tel Aviv University
- August 14, 2010
- One response
- Dr. Moshe Nahamani
- July 19, 2010
- One response
- Dr. Moshe Nahamani
- June 27, 2010
- 2 תגובות
- Dr. Moshe Nahamani
- April 17, 2010
- No comments
- Weizmann Institute
- January 11, 2010
- One response
- Weizmann Institute
- December 22, 2009
- No comments
- Dr.Roey Tsezana
- December 16, 2009
- 6 תגובות
- Tel Aviv University
- November 27, 2009
- 5 תגובות
- The Technion
- November 19, 2009
- One response
- Dr. Moshe Nahamani
- November 5, 2009
- 2 תגובות
- Dr. Moshe Nahamani
- September 29, 2008
- One response
- Dr. Moshe Nahamani
- September 23, 2008
- 4 תגובות
- The Technion
- September 9, 2008
- 3 תגובות
- The science service
- June 26, 2008
- No comments
- The Hebrew University
- June 1, 2008
- No comments
- Popular Science Israel
- October 25, 2003
- No comments